Showing 20,621 - 20,640 results of 36,983 for search '(( significant decrease decrease ) OR ( significant ((clinical decrease) OR (clinical disease)) ))', query time: 0.91s Refine Results
  1. 20621

    Image 1_Interaction between dietary selenium intake and age on severe headache or migraine in the United States: a population-based study.pdf by Xinping Yu (555177)

    Published 2025
    “…</p>Conclusion<p>A higher dietary selenium intake is significantly associated with a decreased prevalence of migraine, and age can modify the association between them. …”
  2. 20622

    Table 1_The role of cyano-phycocyanin as a quorum sensing inhibitor to attenuate Pseudomonas aeruginosa virulence.docx by Jun Ying (129597)

    Published 2025
    “…In vitro, C-PC reduced the adhesion and invasion of PA2 in RAW264.7 cells, and decreased LDH release and macrophage damage caused by PA2 infection. …”
  3. 20623
  4. 20624

    Data_Sheet_1_Efficacy of polygenic risk scores and digital technologies for INNOvative personalized cardiovascular disease PREVention in high-risk adults: protocol of a randomized... by Roberta Pastorino (43253)

    Published 2025
    “…Background<p>Cardiovascular diseases (CVDs) pose a significant global health challenge, necessitating innovative approaches for primary prevention. …”
  5. 20625
  6. 20626

    Interim Effects of Zoledronate, Denosumab, or Teriparatide on Bone Microarchitecture in Type 2 Diabetes: A Pilot Trial by Trupti Nagendra Prasad (17266455)

    Published 2025
    “…</p><p dir="ltr">Design: 72-week, randomized, open-label, blinded-endpoint (PROBE) pilot clinical trial (CTRI/2022/02/039978).</p><p dir="ltr">Setting: Single tertiary care center in India.…”
  7. 20627

    Table 1_Serum alpha-1 acid glycoprotein and gallstone risk in US adult women: a cross-sectional analysis of the NHANES.docx by Xiaocheng Li (1361562)

    Published 2025
    “…Subgroup analyses consistently demonstrated this positive association across various demographic and clinical categories, with significant interactions observed for the ratio of family income to poverty. …”
  8. 20628

    Supplementary Material for: DUAL-GENETIC ETIOLOGY IN AN ATYPICAL DENT DISEASE PHENOTYPE WHICH COMBINES FEATURES OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND ELLIS-VAN CREVELD-LIKE SYN... by figshare admin karger (2628495)

    Published 2025
    “…DD varies in clinical presentation, manifesting with proteinuria alone or in combination with nephrocalcinosis/nephrolithiasis, and with or without chronic kidney disease (CKD), posing a challenge to clinical diagnosis. …”
  9. 20629

    Table 2_Global, regional, and national trends in the burden of bipolar disorder among women of reproductive age from 1990 to 2021, and projections to 2041: a systematic analysis fr... by Feihu Hu (12058091)

    Published 2025
    “…Projections using the BAPC model suggest that ASIR, ASPR, and ASDR may slightly decline by 2041, but the overall disease burden is expected to remain high.</p>Conclusion<p>From 1990 to 2021, the disease burden of BD among women of reproductive age has continued to rise globally, exhibiting significant regional, national, and socioeconomic disparities. …”
  10. 20630

    Table 1_Global, regional, and national trends in the burden of bipolar disorder among women of reproductive age from 1990 to 2021, and projections to 2041: a systematic analysis fr... by Feihu Hu (12058091)

    Published 2025
    “…Projections using the BAPC model suggest that ASIR, ASPR, and ASDR may slightly decline by 2041, but the overall disease burden is expected to remain high.</p>Conclusion<p>From 1990 to 2021, the disease burden of BD among women of reproductive age has continued to rise globally, exhibiting significant regional, national, and socioeconomic disparities. …”
  11. 20631

    Table 4_Exploring research trends and hotspots on PCSK9 inhibitor studies: a bibliometric and visual analysis spanning 2007 to 2023.docx by Ping Lai (3661528)

    Published 2024
    “…Amgen and the Journal of Clinical Lipidology were identified as the most active institution and journal, respectively. …”
  12. 20632

    Table 1_Exploring research trends and hotspots on PCSK9 inhibitor studies: a bibliometric and visual analysis spanning 2007 to 2023.docx by Ping Lai (3661528)

    Published 2024
    “…Amgen and the Journal of Clinical Lipidology were identified as the most active institution and journal, respectively. …”
  13. 20633

    Table 2_Exploring research trends and hotspots on PCSK9 inhibitor studies: a bibliometric and visual analysis spanning 2007 to 2023.docx by Ping Lai (3661528)

    Published 2024
    “…Amgen and the Journal of Clinical Lipidology were identified as the most active institution and journal, respectively. …”
  14. 20634

    Table 3_Exploring research trends and hotspots on PCSK9 inhibitor studies: a bibliometric and visual analysis spanning 2007 to 2023.docx by Ping Lai (3661528)

    Published 2024
    “…Amgen and the Journal of Clinical Lipidology were identified as the most active institution and journal, respectively. …”
  15. 20635

    Table 6_Exploring research trends and hotspots on PCSK9 inhibitor studies: a bibliometric and visual analysis spanning 2007 to 2023.docx by Ping Lai (3661528)

    Published 2024
    “…Amgen and the Journal of Clinical Lipidology were identified as the most active institution and journal, respectively. …”
  16. 20636

    Table 7_Exploring research trends and hotspots on PCSK9 inhibitor studies: a bibliometric and visual analysis spanning 2007 to 2023.docx by Ping Lai (3661528)

    Published 2024
    “…Amgen and the Journal of Clinical Lipidology were identified as the most active institution and journal, respectively. …”
  17. 20637

    Table 5_Exploring research trends and hotspots on PCSK9 inhibitor studies: a bibliometric and visual analysis spanning 2007 to 2023.docx by Ping Lai (3661528)

    Published 2024
    “…Amgen and the Journal of Clinical Lipidology were identified as the most active institution and journal, respectively. …”
  18. 20638
  19. 20639
  20. 20640